Keywords: alizyme, colitis, drug, clears, phase, ii, trial
Alizyme colitis drug clears Phase II trial
Article | 25 February 2002
Alizyme of the UK has reported positive preliminary results in a PhaseII trial of COLAL-PRED (prednisolone sodium metasulphobenzoate) in patients ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
